—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Virbac SA (VIRP.PA) — chart, structure and Closelooknet read

The Closelooknet read

Virbac makes health products for pets and farm animals, including vaccines, parasiticides, antibiotics, anti-inflammatories, dermatology treatments, diagnostics and pet food, sold to vets, farmers and pet owners across many regions. It is headquartered in Carros, France.

Detail below: the desk's view, the earnings record, peers and the company snapshot; daily prices on the price-history tab. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for VIRP.PA, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 48/100 · S&P 500 fund at 51, above its 200-day averageEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-11-10
  • Factor regime Defensive rotation — low-vol leading, regime-change watchMomentum against low volatility (SPMO / SPLV): below its 50-day trend, 67th percentile of the window, -18.1% over 20 sessions. Factor regime → 2026-11-10
  • Sector × region Health care in Europe: +2.4% week · +14.5% month · +11.7% quarter · +16.3% yearThe Sector Engine cell this name lives in, from EXV4.XETRA; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-11-10
  • Sovereign pressure Index -1.67 · down 1.71 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-11-09
Who it is priced against Drug Manufacturers - General · 8 names with week and year-to-date

Peer group

Drug Manufacturers - General

Names in the same industry from the Closelooknet universe; scored names rank on their Closelooknet score, the rest on trend state.

Compared against VIRP.PA on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Virbac SA

VIRP.PA in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Virbac makes health products for pets and farm animals, including vaccines, parasiticides, antibiotics, anti-inflammatories, dermatology treatments, diagnostics and pet food, sold to vets, farmers and pet owners across many regions. It is headquartered in Carros, France.
Where it sits in the stack
Virbac sits outside our AI build-out coverage; it belongs to the Healthcare sector of the wider universe, in the veterinary pharmaceuticals and animal-health sleeve rather than any Closelooknet index.
Who it is priced against
Closelooknet has not placed Virbac in a peer group; the comparison the market draws is with Zoetis, the larger listed animal-health company.
Why Closelooknet tracks it
Virbac holds no seat in any Closelooknet index, carries no Closelooknet score, and does not appear among the diary's quoted names or editions.
What the diary watches
The diary watches whether the recent pullback below its trend lines steadies, since Virbac's business turns on veterinary and farm demand rather than any AI-related driver.

Virbac SA (VIRP.PA) trades on the PA exchange in France, classified under Healthcare.

The Closelooknet company score reads 50/100 composite (momentum 61, quality 52, valuation 55) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Dividends and capital return trailing yield 0.41%, annual · last 1.45 EUR on 2026-07-02

Dividends and capital return

What VIRP.PA pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 1.45 EUR per share · a 0.41% yield on the 2026-11-10 close 1 distribution, paid once a year 2026-11-10
  • Change on the year 0.0% against the prior twelve months prior twelve months 1.45 EUR per share
  • Last distribution 1.45 EUR per share as the price series records it, within days of the ex-date 2026-07-02
  • By calendar year 2025: 1.45 EUR (partial) · 2026: 1.45 EUR to date first distribution recorded in the three-year window: 2025-06-24
  • Dividends paid, FY2025 12 m EUR 8% of earnings
  • Share count +0.1% in FY2025
  • Capital returned 12 m EUR · 12% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-11-11

Quick answers

What is Virbac SA (VIRP.PA)?

Virbac SA trades as VIRP.PA on the PA exchange (France) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-11-11.

Is VIRP.PA in a Closelooknet index?

Not currently — Virbac SA is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-11-11.

What is Virbac SA's Closelooknet composite score?

50 out of 100, with momentum 61, quality 52 and valuation 55 sub-scores, as of 2026-11-11. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does VIRP.PA trade against its moving averages?

Virbac SA trades 9.4% above its 50-day and 4.7% above its 200-day moving average (2.5% above its 20-day). As of 2026-11-10 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Virbac SA compare with its peers?

Against its peer group (Drug Manufacturers - General), Virbac SA (VIRP.PA) sits 7.8% below its 52-week high, 9.4% above its 50-day average; Eli Lilly and Company (LLY) is 2.8% below, Orion Oyj A (ORNAV.HE) is 1.4% below, Orion Oyj B (ORNBV.HE) is 1.4% below, as of 2026-11-10. Put any of them next to VIRP.PA in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

What does Virbac SA do?

Virbac makes health products for pets and farm animals, including vaccines, parasiticides, antibiotics, anti-inflammatories, dermatology treatments, diagnostics and pet food, sold to vets, farmers and pet owners across many regions. It is headquartered in Carros, France. Closelooknet has not placed Virbac in a peer group; the comparison the market draws is with Zoetis, the larger listed animal-health company. (Company snapshot of 2026-09-17.)

Where does Virbac SA sit in the AI build-out?

Virbac sits outside our AI build-out coverage; it belongs to the Healthcare sector of the wider universe, in the veterinary pharmaceuticals and animal-health sleeve rather than any Closelooknet index. Virbac holds no seat in any Closelooknet index, carries no Closelooknet score, and does not appear among the diary's quoted names or editions. (Company snapshot of 2026-09-17.)

Does Virbac SA pay a dividend?

Virbac SA has paid 1.45 EUR per share over the last twelve months, paid once a year, a trailing yield of 0.41% on the 2026-11-10 close; the last distribution recorded in the price series was 1.45 EUR on 2026-07-02. In fiscal 2025 the company paid 12 m EUR in dividends, 12% of that year’s free cash flow. The share count rose 0.1% over the fiscal year. As of 2026-11-10; the "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for VIRP.PA, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

How to use this chart

Toolbar

  • Range — 1M to MAX on daily closes. 1D/5D switch a US stock cell to 5-minute intraday bars; index and foreign cells fall back to 1M daily with a note.
  • Grid — 1×1 up to 2×2. Cells are synchronized: pan or zoom one and the others follow the same dates; the crosshair tracks across all of them. 4 INDICES loads Rubin · HALO · AEI · AW40 side by side.
  • Type / Scale — OHLC, line or area; linear or log price axis.

Picking a series

  • Tap the box in a cell's header to browse every Closelooknet series — headline indices, sub-indices, sectors, layers of all six families — plus the constituents.
  • Or type any ticker (NVDA, 7203.T, ASML.AS …) and press Enter — it charts in the cell straight from our data lake.

Studies

  • Overlays / Oscillators rows toggle the standard set (SMA, Bollinger, RSI, MACD …) per cell.
  • Levels (stock cells) draws the structure engine's support lines — regression bands, pivot cluster, SMA-200, the active fib zone.

Drawing

  • Tap a tool (Trend, Ray, H-Line, Fib, Channel, Rect, Note), then tap the chart once per point — the shape follows your finger or cursor between taps. The chart stops panning while a tool is armed; tap the tool again to release.
  • Drawings save per symbol in this browser and travel between the terminal and the asset page.
  • Delete key removes the selected drawing · Escape cancels a half-placed one · Clear wipes the symbol.

Wave counts

  • Wave places an Elliott count: tap the origin, then each wave end. Press Enter to stop early (inside wave 3 is fine) — dotted ghost targets sketch the remaining waves at guideline ratios.
  • On stocks the scanner's machine count appears automatically in grey — it is fully editable: drag any point, double-tap a label to remove it, Delete to dismiss it for good, Adopt to bring the machine's proposal back.
  • The sequence picker switches 1-5 / A-B-C / A-E / W-X-Y-Z; 1 2 3 cycles the degree; Subdiv starts a one-degree-smaller child count inside a wave.

Sharing

  • Card exports the cell as a branded PNG — chart, drawings and levels exactly as shown.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.